Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Other Non-Current Liabilities came in at $38.5 million in Q2 2026, up 4.05% on a YoY basis from $37.0 million in Q2 2025, and up 1.85% quarter-over-quarter from $37.8 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Other Non-Current Liabilities for 5 consecutive years, with $38.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Liabilities rose 4.05% year-over-year to $38.5 million; the trailing twelve-month figure through Jun 2026 stood at $38.5 million (up 4.05% YoY), and the FY2025 full-year result was $39.3 million, up 11.33% from the prior year.
  • Other Non-Current Liabilities grew to $38.5 million in Q2 2026 per FTRE's latest filing, from $37.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $39.3 million in Q4 2025 and bottomed at $21.7 million in Q4 2022.
  • Historically, Other Non-Current Liabilities has averaged $34.5 million across 5 years, with a median of $36.4 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Liabilities jumped 47.93% in 2023, then fell 20.0% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $21.7 million in 2022, then surged by 47.93% to $32.1 million in 2023, then climbed by 9.97% to $35.3 million in 2024, then climbed by 11.33% to $39.3 million in 2025, then fell by 2.04% to $38.5 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $38.5 million, $37.8 million, and $39.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.50 Mn
Mar 31, 2026 37.80 Mn
Dec 31, 2025 39.30 Mn
Sep 30, 2025 36.40 Mn
Jun 30, 2025 37.00 Mn
Mar 31, 2025 36.30 Mn
Dec 31, 2024 35.30 Mn
Sep 30, 2024 37.60 Mn
Jun 30, 2024 29.60 Mn
Mar 31, 2024 28.90 Mn
Dec 31, 2023 32.10 Mn
Sep 30, 2023 35.70 Mn
Jun 30, 2023 37.00 Mn
Dec 31, 2022 21.70 Mn